Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut. 2024;73(4):691–702.

PubMed  CAS  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966–86.

Article  PubMed  Google Scholar 

Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50:101238.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Scoditti E, Sabatini S, Carli F, Gastaldelli A. Hepatic glucose metabolism in the steatotic liver. Nat Rev Gastroenterol Hepatol. 2024;21(5):319–34.

Article  PubMed  Google Scholar 

Li Y, Yang P, Ye J, Xu Q, Wu J, Wang Y. Updated mechanisms of MASLD pathogenesis. Lipids Health Dis. 2024;23(1):117.

Article  PubMed  PubMed Central  Google Scholar 

Hsu YJ, Wang CY, Lee MC, Huang CC. Hepatoprotection by traditional essence of ginseng against carbon tetrachloride-induced liver damage. Nutrients. 2020;12(10):3214.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gallage S, Avila JEB, Ramadori P, Focaccia E, Rahbari M, Ali A, et al. A researcher’s guide to preclinical mouse NASH models. Nat Metab. 2022;4(12):1632–49.

Article  PubMed  CAS  Google Scholar 

Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018;38(1):27.

PubMed  Google Scholar 

Du Z, Lin L, Li Y, Sun M, Liang Q, Sun Z, et al. Combined exposure to PM(2.5) and high-fat diet facilitates the hepatic lipid metabolism disorders via ROS/miR-155/PPARgamma pathway. Free Radic Biol Med. 2022;190:16–27.

Article  PubMed  CAS  Google Scholar 

Zhu W, Hong Y, Tong Z, He X, Li Y, Wang H, et al. Activation of hepatic adenosine A1 receptor ameliorates MASH via inhibiting SREBPs maturation. Cell Rep Med. 2024;5(3):101477.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Luo W, Dai J, Liu J, Huang Y, Zheng Z, Xu P, et al. PACAP attenuates hepatic lipid accumulation through the FAIM/AMPK/IRβ axis during overnutrition. Mol Metab. 2022;65:101584.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xia Q, Lu F, Chen Y, Li J, Huang Z, Fang K, et al. 6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway. Biomed Pharmacother. 2024;170:116060.

Article  PubMed  CAS  Google Scholar 

Sommerauer C, Gallardo-Dodd CJ, Savva C, Hases L, Birgersson M, Indukuri R, et al. Estrogen receptor activation remodels TEAD1 gene expression to alleviate hepatic steatosis. Mol Syst Biol. 2024;20(4):374–402.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Huang SJ, Chen SQ, Lin Y, Yang HY, Ran J, Yan FF, et al. Maternal nicotine exposure aggravates metabolic associated fatty liver disease via PI3K/Akt signaling in adult offspring mice. Liver Int. 2021;41(8):1867–78.

Article  PubMed  CAS  Google Scholar 

Cheng X, Baki VB, Moran M, Liu B, Yu J, Zhao M, et al. Liver matrin-3 protects mice against hepatic steatosis and stress response via constitutive androstane receptor. Mol Metab. 2024;86:101977.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jiang Y, Luo P, Cao Y, Peng D, Huo S, Guo J, et al. The role of STAT3/VAV3 in glucolipid metabolism during the development of HFD-induced MAFLD. Int J Biol Sci. 2024;20(6):2027–43.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jiang P, Zeng Y, Yang W, Li L, Zhou L, Xiao L, et al. The effects of Fc fusion protein glucagon-like peptide-1 and glucagon dual receptor agonist with different receptor selectivity in vivo studies. Biomed Pharmacother. 2024;174:116485.

Article  PubMed  CAS  Google Scholar 

Yang JW, Zou Y, Chen J, Cui C, Song J, Yang MM, et al. Didymin alleviates metabolic dysfunction-associated fatty liver disease (MAFLD) via the stimulation of Sirt1-mediated lipophagy and mitochondrial biogenesis. J Transl Med. 2023;21(1):921.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mu JK, Zi L, Li YQ, Yu LP, Cui ZG, Shi TT, et al. Jiuzhuan Huangjing Pills relieve mitochondrial dysfunction and attenuate high-fat diet-induced metabolic dysfunction-associated fatty liver disease. Biomed Pharmacother. 2021;142:112092.

Article  PubMed  CAS  Google Scholar 

Qiu YY, Zhang J, Zeng FY, Zhu YZ. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Pharmacol Res. 2023;192:106786.

Article  PubMed  CAS  Google Scholar 

Choi SW, Oh H, Park SY, Cho W, Abd El-Aty AM, Baygutalp NK, et al. Netrin-1 attenuates hepatic steatosis via UNC5b/PPARgamma-mediated suppression of inflammation and ER stress. Life Sci. 2022;311(Pt B):121149.

Article  PubMed  CAS  Google Scholar 

Sun F, Yang Y, Jia L, Dong QQ, Hu W, Tao H, et al. TET3 boosts hepatocyte autophagy and impairs non-alcoholic fatty liver disease by increasing ENPP1 promoter hypomethylation. Free Radic Biol Med. 2024;218:166–77.

Article  PubMed  CAS  Google Scholar 

Yuan Z, Qiao H, Wang Z, Wang H, Han M, Zhang W, et al. Taohe Chengqi decoction alleviated metabolic-associated fatty liver disease by boosting branched chain amino acids catabolism in the skeletal muscles of type 2 diabetes mellitus. Phytomedicine. 2024;126:155315.

Article  PubMed  CAS  Google Scholar 

Sahin C, Melanson JR, Le Billan F, Magomedova L, Ferreira TAM, Oliveira AS, et al. A novel fatty acid mimetic with pan-PPAR partial agonist activity inhibits diet-induced obesity and metabolic dysfunction-associated steatotic liver disease. Mol Metab. 2024;85:101958.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lee WH, Kim SG. AMPK-dependent metabolic regulation by PPAR agonists. PPAR Res. 2010;2010:1–10.

Article  Google Scholar 

Ma C, Wang Z, Xia R, Wei L, Zhang C, Zhang J, et al. Danthron ameliorates obesity and MAFLD through activating the interplay between PPARalpha/RXRalpha heterodimer and adiponectin receptor 2. Biomed Pharmacother. 2021;137:111344.

Article  PubMed  CAS  Google Scholar 

Gebreyesus LH, Choi S, Neequaye P, Mahmoud M, Mahmoud M, Ofosu-Boateng M, et al. Pregnane X receptor knockout mitigates weight gain and hepatic metabolic dysregulation in female C57BL/6 J mice on a long-term high-fat diet. Biomed Pharmacother. 2024;173:116341.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Morgan D, Garg M, Tergaonkar V, Tan SY, Sethi G. Pharmacological significance of the non-canonical NF-kappaB pathway in tumorigenesis. Biochim Biophys Acta Rev Cancer. 2020;1874(2):188449.

Article  PubMed  CAS  Google Scholar 

Lyu Y, Yang X, Yang L, Dai J, Qin H, Zhou Y, et al. Lipid nanoparticle-mediated hepatocyte delivery of siRNA and silibinin in metabolic dysfunction-associated steatotic liver disease. J Control Release. 2024;373:385–98.

Article  PubMed  CAS  Google Scholar 

Zakaria Z, Othman ZA, Suleiman JB, Che Jalil NA, Ghazali WSW, Nna VU, et al. Hepatoprotective effect of bee bread in metabolic dysfunction-associated fatty liver disease (MAFLD) rats: impact on oxidative stress and inflammation. Antioxidants (Basel). 2021;10(12):2031.

Article